等待开盘 11-05 09:30:00 美东时间
-1.720
-0.35%
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08
Neuropace, Inc. (($NPCE)) announced an update on their ongoing clinical study. ...
10-28 03:49
Carrier Global (NYSE:CARR) is set to give its latest quarterly earnings report ...
10-28 00:02
Lennox (NYSE:LII) filed automatic mixed securities shelf. Filing More on Lennox Lennox International Is Getting Close To A Downgrade Lennox updates 2025 outlook to 1% sales decline and $22.75-$23.25 E...
10-25 05:26
今日重点评级关注:摩根士丹利:维持Viking Therapeutics"超配"评级,目标价从98美元升至102美元;摩根大通:维持IDEAYA Biosciences"超配"评级,目标价从74美元升至79美元
10-24 09:51
Lennox Intl (NYSE:LII) has been analyzed by 8 analysts in the last three months...
10-23 20:00
Morgan Stanley analyst Betsy Graseck maintains Lennox Intl (NYSE:LII) with a Underweight and lowers the price target from $535 to $475.
10-23 19:39
Lennox International ( ($LII) ) has released its Q3 earnings. Here is a breakdo...
10-23 12:08
华盛资讯10月23日讯,LENNOX INTERNATIONAL公司今日公布2025财年Q3业绩,公司Q3营收14.27亿美元,同比下降4.8%,股权持有人应占溢利2.46亿美元,同比增长2.8%。
10-23 02:02